CHESTER, NY / ACCESSWIRE / October 16, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR)
today announced that it will release its financial results for the third quarter ended September 30, 2018, after the close of the
financial markets on Tuesday, October 23, 2018.
An accompanying conference call will be hosted by Dan Goldberger, Chairman and interim Chief Executive Officer, Karen Fisher,
Chief Financial Officer and Don Pettigrew, President and Chief Commercial Officer. The call will be held at 9:00AM ET, on
Wednesday, October 24 2018. Please refer to the information below for conference call dial-in information and webcast
registration.
Conference Details
Conference Date: Wednesday, October 24, 2018 9:00 AM ET
Conference Dial-In: 877.269.7756
International Dial-In: 201.689.7817
Conference Call Name: RMS Medical Products (OTCQX: REPR) Third Quarter 2018 Results Call
Webcast Registration: Click Here
Following the live call, a replay will be available for six months on the Company's website, www.rmsmedpro.com, under "Investor Relations."
About RMS Medical Products
The Company develops, manufactures and commercializes medical products used for home infusions and suctioning. The FREEDOM
Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate
Tubing™ and RMS HIgHFlo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional
healthcare settings as well as at home. The Company's RESQVAC® line of medical suctioning products is used by emergency medical
service providers in addition to a variety of other healthcare providers. For more information about RMS Medical Products, please
visit www.rmsmedicalproducts.com.
Contact
CG Capital
877.889.1972
investorrelations@cg.capital
www.cg.capital
SOURCE: Repro Med Systems, Inc.
